Healthcare provider profile · identity verified

Suzanne Carr, MD

Family Practice · BRUNSWICK, ME · NPI 1679513402

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	572	153
Levothyroxine Sodium	Levothyroxine Sodium	449	99
Amlodipine Besylate	Amlodipine Besylate	445	124
Losartan Potassium	Losartan Potassium	338	89
Lisinopril	Lisinopril	323	88
Omeprazole	Omeprazole	242	71
Hydrochlorothiazide	Hydrochlorothiazide	222	64
Gabapentin	Gabapentin	204	48
Metoprolol Succinate	Metoprolol Succinate	179	47
Sertraline Hcl	Sertraline Hcl	143	39
Simvastatin	Simvastatin	142	38
Rosuvastatin Calcium	Rosuvastatin Calcium	133	43
Eliquis	Apixaban	132	30
Alendronate Sodium	Alendronate Sodium	131	38
Metformin Hcl	Metformin Hcl	112	30
Furosemide	Furosemide	106	26
Lorazepam	Lorazepam	104	31
Fluticasone Propionate	Fluticasone Propionate	100	37
Escitalopram Oxalate	Escitalopram Oxalate	99	26
Metoprolol Tartrate	Metoprolol Tartrate	99	27
Albuterol Sulfate Hfa	Albuterol Sulfate	96	45
Trazodone Hcl	Trazodone Hcl	94	25
Famotidine	Famotidine	80	20
Tramadol Hcl	Tramadol Hcl	80	21
Citalopram Hbr	Citalopram Hydrobromide	77	19
Pantoprazole Sodium	Pantoprazole Sodium	76	18
Glipizide Er	Glipizide	71	19
Fluoxetine Hcl	Fluoxetine Hcl	69	18
Atenolol	Atenolol	68	18
Potassium Chloride	Potassium Chloride	68	13
Oxycodone Hcl	Oxycodone Hcl	67	18
Bupropion Xl	Bupropion Hcl	60	13
Tamsulosin Hcl	Tamsulosin Hcl	59	15
Labetalol Hcl	Labetalol Hcl	58	14
Allopurinol	Allopurinol	57	15
Alprazolam	Alprazolam	56	13
Prednisone	Prednisone	54	27
Spironolactone	Spironolactone	53	11
Zolpidem Tartrate	Zolpidem Tartrate	52	16
Jardiance	Empagliflozin	51	14
Duloxetine Hcl	Duloxetine Hcl	48	14
Lovastatin	Lovastatin	48	11
Clonazepam	Clonazepam	44	11
Bupropion Hcl Sr	Bupropion Hcl	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	12
Ozempic	Semaglutide	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Nystatin	Nystatin	35	22
Warfarin Sodium	Warfarin Sodium	35	suppressed
Estradiol	Estradiol	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	29
Baclofen	Baclofen	31	11
Carvedilol	Carvedilol	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Finasteride	Finasteride	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	24
Eszopiclone	Eszopiclone	27	suppressed
Torsemide	Torsemide	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Montelukast Sodium	Montelukast Sodium	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Diazepam	Diazepam	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Telmisartan	Telmisartan	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error